Tobacco tax hike leads to Champix shortage in Japan
This article was originally published in Scrip
Executive Summary
Pfizer cannot meet local demand for its smoking cessation drug Champix (varenicline) in Japan following a surge in the number of people looking to quit following a tobacco tax hike on 1 October.